Literature DB >> 21233841

IDH1 and IDH2 mutations are rare in pediatric myeloid malignancies.

K Oki, J Takita, M Hiwatari, R Nishimura, M Sanada, J Okubo, M Adachi, M Sotomatsu, A Kikuchi, T Igarashi, Y Hayashi, S Ogawa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21233841     DOI： 10.1038/leu.2010.307

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   12.883


× No keyword cloud information.
  9 in total

1.  Parallel targeted next generation sequencing of childhood and adult acute myeloid leukemia patients reveals uniform genomic profile of the disease.

Authors:  Irena Marjanovic; Jelena Kostic; Bojana Stanic; Nadja Pejanovic; Bojana Lucic; Teodora Karan-Djurasevic; Dragana Janic; Lidija Dokmanovic; Srdja Jankovic; Nada Suvajdzic Vukovic; Dragica Tomin; Ognjen Perisic; Goran Rakocevic; Milos Popovic; Sonja Pavlovic; Natasa Tosic
Journal:  Tumour Biol       Date:  2016-07-27

Review 2.  Somatic mosaic mutations of IDH1 and NPM1 associated with cup-like acute myeloid leukemia in a patient with Maffucci syndrome.

Authors:  Masaharu Akiyama; Masayoshi Yamaoka; Yoko Mikami-Terao; Wataru Ohyama; Kentaro Yokoi; Yasuhiro Arakawa; Junko Takita; Hideaki Suzuki; Hisashi Yamada
Journal:  Int J Hematol       Date:  2015-10-27       Impact factor: 2.490

3.  Novel splicing-factor mutations in juvenile myelomonocytic leukemia.

Authors:  J Takita; K Yoshida; M Sanada; R Nishimura; J Okubo; A Motomura; M Hiwatari; K Oki; T Igarashi; Y Hayashi; S Ogawa
Journal:  Leukemia       Date:  2012-02-20       Impact factor: 11.528

Review 4.  Isocitrate dehydrogenase mutations in leukemia.

Authors:  Anna Sophia McKenney; Ross L Levine
Journal:  J Clin Invest       Date:  2013-09-03       Impact factor: 19.456

5.  IDH1 and IDH2 mutations in pediatric acute leukemia.

Authors:  A K Andersson; D W Miller; J A Lynch; A S Lemoff; Z Cai; S B Pounds; I Radtke; B Yan; J D Schuetz; J E Rubnitz; R C Ribeiro; S C Raimondi; J Zhang; C G Mullighan; S A Shurtleff; B A Schulman; J R Downing
Journal:  Leukemia       Date:  2011-06-07       Impact factor: 12.883

6.  Copy number variations in atypical fibroxanthomas and pleomorphic dermal sarcomas.

Authors:  Doris Helbig; Alexander Quaas; Cornelia Mauch; Sabine Merkelbach-Bruse; Reinhard Büttner; Michael Emberger; Marion Wobser; Vanessa Rüsseler; Katharina Pütz; Elke Binot; Jan Rehker; Jan Budczies; Michaela Angelika Ihle
Journal:  Oncotarget       Date:  2017-11-25

Review 7.  Isocitrate dehydrogenase gene variants in cancer and their clinical significance.

Authors:  Thomas Cadoux-Hudson; Christopher J Schofield; James S O McCullagh
Journal:  Biochem Soc Trans       Date:  2021-12-17       Impact factor: 5.407

Review 8.  Metabolic adaptations in cancers expressing isocitrate dehydrogenase mutations.

Authors:  Ingvild Comfort Hvinden; Tom Cadoux-Hudson; Christopher J Schofield; James S O McCullagh
Journal:  Cell Rep Med       Date:  2021-12-21

9.  Oncogene and therapeutic target analyses in atypical fibroxanthomas and pleomorphic dermal sarcomas.

Authors:  Doris Helbig; Michaela Angelika Ihle; Katharina Pütz; Iliana Tantcheva-Poor; Cornelia Mauch; Reinhard Büttner; Alexander Quaas
Journal:  Oncotarget       Date:  2016-04-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.